Drug Type Recombinant protein |
Synonyms |
Target |
Mechanism FGF21R agonists, GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | CN | 04 Apr 2023 | |
Nonalcoholic Steatohepatitis | Preclinical | CN | - |